MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
2018-11-19T05:00:00Z (GMT)
by
Additional file 6: Table S6. Omalizumab-treated patients to divide into 4 groups according to serum TNC and Periostin levels.
Categories
License
CC BY + CC0